Cargando…

VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway

BACKGROUND: Glioblastoma (GBM) is the most common malignant primary brain tumour in adults. VSIG4 has been identified to be associated with GBM. We aimed to determine the downstream regulatory mechanisms of VSIG4 in GBM. METHODS: Differential expression of VSIG4 was analysed using GEPIA. The express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Congying, Mao, Chengliang, Tang, Kai, Shu, Hang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246575/ https://www.ncbi.nlm.nih.gov/pubmed/37292180 http://dx.doi.org/10.2147/NDT.S406782

Ejemplares similares

VSIG4 interaction with heparan sulfates inhibits VSIG4–complement binding
por: Ebstein, Sarah Y, et al.
Publicado: (2023)

Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway
por: Zheng, Xiaoxia, et al.
Publicado: (2021)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism
por: Li, Jialin, et al.
Publicado: (2017)

The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment
por: Fahmideh, Hanieh, et al.
Publicado: (2022)

Structural Basis of VSIG3: The Ligand for VISTA
por: Xie, Xiaoxue, et al.
Publicado: (2021)

Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway
por: Jia, Fei, et al.
Publicado: (2022)

The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
por: Ou, Alexander, et al.
Publicado: (2021)

Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway
por: Xu, Peng, et al.
Publicado: (2022)

VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages
por: Huang, Xiaoyong, et al.
Publicado: (2019)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway
por: Mao, Yuan, et al.
Publicado: (2016)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
por: Harel, Sivan, et al.
Publicado: (2015)

Lp-PLA2 silencing ameliorates inflammation and autophagy in nonalcoholic steatohepatitis through inhibiting the JAK2/STAT3 pathway
por: Yao, Jinmei, et al.
Publicado: (2023)

Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
por: Yang, Shuqun, et al.
Publicado: (2015)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

Regulation of proliferation, cell competition, and cellular growth by the Drosophila JAK-STAT pathway
por: Zoranovic, Tamara, et al.
Publicado: (2013)

Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo
por: Judd, Louise M., et al.
Publicado: (2014)

The effect of valproic acid on intrinsic, extrinsic, and JAK/STAT pathways in neuroblastoma and glioblastoma cell lines
por: Sanaei, Masumeh, et al.
Publicado: (2022)

Acteoside inhibits inflammatory response via JAK/STAT signaling pathway in osteoarthritic rats
por: Qiao, Zhiguang, et al.
Publicado: (2019)

JAK-STAT pathway and myogenic differentiation
por: Jang, You-Na, et al.
Publicado: (2013)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
por: Han, Sang Youb, et al.
Publicado: (2022)

Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway
por: Li, Hongbo, et al.
Publicado: (2018)

The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
por: Goker Bagca, Bakiye, et al.
Publicado: (2020)

Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway
por: Chen, Liwen, et al.
Publicado: (2018)

Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway
por: Wang, Weiguo, et al.
Publicado: (2019)

FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
por: Li, Xujun, et al.
Publicado: (2023)

Silencing of ISLR inhibits tumour progression and glycolysis by inactivating the IL-6/JAK/STAT3 pathway in non-small cell lung cancer
por: Zhang, Peng, et al.
Publicado: (2021)

The significance of microRNA-184 on JAK2/STAT3 signaling pathway in the formation mechanism of glioblastoma
por: ZHANG, XUEKUI, et al.
Publicado: (2015)

JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)

Effect of JAK-STAT pathway in regulation of fatty liver hemorrhagic syndrome in chickens
por: Zhu, Yaling, et al.
Publicado: (2021)

Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
por: Li, Shasha, et al.
Publicado: (2013)

The JAK/STAT Pathway Is Involved in Synaptic Plasticity
por: Nicolas, Céline S., et al.
Publicado: (2012)

Methotrexate Is a JAK/STAT Pathway Inhibitor
por: Thomas, Sally, et al.
Publicado: (2015)

The JAK/STAT Pathway in Skeletal Muscle Pathophysiology
por: Moresi, Viviana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3qpl3dbifmsql5fog4k0uo96er